data_sheet_1_Glucocorticoid-Induced Leucine Zipper Inhibits Interferon-Gamma Production in B Cells and Suppresses Colitis in Mice.PDF
收藏frontiersin.figshare.com2023-05-30 更新2025-01-15 收录
下载链接:
https://frontiersin.figshare.com/articles/dataset/data_sheet_1_Glucocorticoid-Induced_Leucine_Zipper_Inhibits_Interferon-Gamma_Production_in_B_Cells_and_Suppresses_Colitis_in_Mice_PDF/6849407/1
下载链接
链接失效反馈官方服务:
资源简介:
Glucocorticoid-induced leucine zipper (GILZ) is transcriptionally upregulated by glucocorticoids (GCs) and mediates many of the anti-inflammatory effects of GCs. Since B cell activity has been linked to cytokine production and modulation of inflammatory responses, we herein investigated the role of GILZ in B cells during colitis development. B cell-specific gilz knock-out (gilz B cKO) mice exhibited increased production of the pro-inflammatory cytokine IFN-γ in B cells, and consequently CD4+ T cell activation. Increased IFN-γ production in B cells was associated with enhanced transcriptional activity of the transcription factor activator protein-1 (AP-1) on the IFN-γ promoter. Moreover, GILZ deficiency in B cells was linked to enhanced susceptibility to experimental colitis in mice, and this was reversed by administering GILZ protein. Interestingly, we observed increased production of IFN-γ in both B and T cells infiltrating the lamina propria (LP) of gilz B cKO mice. Together, these findings indicate that GILZ controls IFN-γ production in B cells, which also affects T cell activity, and increased production of IFN-γ by B and T cells in LP is associated with predisposition to inflammatory colitis in mice.
糖皮质激素诱导的亮氨酸拉链蛋白(GILZ)在糖皮质激素(GCs)的转录调控下表达上调,并介导了GCs的多种抗炎作用。鉴于B细胞活性与细胞因子产生以及对炎症反应的调节密切相关,本研究旨在探讨GILZ在结肠炎发展过程中B细胞中的作用。B细胞特异性gilz敲除(gilz B cKO)小鼠表现出B细胞中促炎细胞因子IFN-γ的产生增加,进而导致CD4+ T细胞的激活。B细胞中IFN-γ产生的增加与转录因子激活蛋白-1(AP-1)在IFN-γ启动子上的转录活性增强有关。此外,B细胞中GILZ的缺乏与小鼠实验性结肠炎的易感性增加有关,且通过给予GILZ蛋白可以逆转这一现象。有趣的是,我们在gilz B cKO小鼠的固有层(LP)浸润的B和T细胞中观察到IFN-γ的产生增加。综上所述,这些发现表明GILZ调控B细胞中的IFN-γ产生,这不仅影响T细胞活性,而且LP中B和T细胞IFN-γ的产生增加与小鼠易患炎症性结肠炎有关。
提供机构:
Frontiers



